β-cyclodextrin news

All news on β-cyclodextrin (also known as cyclodextrin, betadex, and Cavamax W7): plants, production capacities, investments and involved companies.

30 July 2026

WACKER Q2 2026 results — PACE savings and pension effect boost earnings

Q2 sales €1.52bn; EBITDA €211m aided by cost cuts and a €36.7m pension revaluation; net income includes €243m from Siltronic sale; full‑year guidance adjusted.
14 April 2026

WACKER and Amyris partner on bio-based personal-care ingredients

Develop bio-based functional ingredients for cosmetics; expand silicone range with renewable raw materials; test novel molecules and production integration.

Who will be producing β-cyclodextrin in the future?

Find out with chemXplore Alpha

Learn more